ArticleJournal of managed care & specialty pharmacy2025

Tirzepatide vs semaglutide and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States.

Ligang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.